Overview Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD).
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Live Event
Increasing Awareness Of Autosomal Dominant Polycystic Kidney Disease (ADPKD) In Underrepresented & Underserved Communities
This presentation focuses on the impact of kidney disease and autosomal dominant polycystic kidney disease (ADPKD) in Black and Hispanic/Latino communities and the effects of social determinants of health on patients living with kidney. Diagnosing and managing the care of patients living with ADPKD will also be discussed.
Genetic Testing in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be discussed.
Autosomal Dominant Polycystic Kidney Disease: The Role of Imaging in Diagnosis & Prognosis
In this presentation, we will discuss the important role of imaging in diagnosis and prognosis of ADPKD, including measuring TKV, looking at complications and more.
Understanding Polycystic Kidney Disease: An Overview of PKD
This presentation for patients will discuss how Polycystic Kidney Disease (PKD) develops, how the disease changes over time, and how it affects patients both physically and mentally.
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
